Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.
Country of origin: USA
Click for Full Details: www.ncbi.nlm.nih.govA study conducted by Dr. Fukuda and colleagues, evaluated NAFLD as a risk marker for type 2 diabetes.1 The researchers evaluated data of >4500 patients who were part of a health checkup program over a 12-year period. In non-obese patients, NAFLD pushed the rate of diabetes from 3.2% to 14.4%, which is almost four times the rate of diabetes compared with that in people without NAFLD. For obese patients, NAFLD moved the rate of diabetes from 8% to 26.4%, which is a little over three times the rate of diabetes compared with that in people without NAFLD. The conclusion drawn by the researchers is that NAFLD is independent of BMI for prediction of diabetes.
Click for Full Details: www.ncbi.nlm.nih.gov
Clinical Pain Advisor. December 2018
Managing Head Injury. December 2018
OrthoFlow pocket orthopaedic specialist. December 2018
inPractice® Oncology. December 2018
Counter Fraud Authority November 2018
Game Plan to Prevent Type 2 Diabetes November 2018
Visual communication can benefit all audiences November 2018
Prevention of HAI Observation Tools November 2018
Pre - Diabetes Test November 2018
The CDC Clear Communication Index November 2018